- Home
- RHE vs XXII Comparison
RHE vs XXII Comparison
Compare RHE & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RHE
- XXII
- Stock Information
- Founded
- RHE 1988
- XXII 1998
- Country
- RHE United States
- XXII United States
- Employees
- RHE N/A
- XXII N/A
- Industry
- RHE Real Estate
- XXII Medicinal Chemicals and Botanical Products
- Sector
- RHE Real Estate
- XXII Health Care
- Exchange
- RHE Nasdaq
- XXII Nasdaq
- Market Cap
- RHE 3.5M
- XXII 4.0M
- IPO Year
- RHE 2006
- XXII N/A
- Fundamental
- Price
- RHE $1.57
- XXII $0.09
- Analyst Decision
- RHE
- XXII
- Analyst Count
- RHE 0
- XXII 0
- Target Price
- RHE N/A
- XXII N/A
- AVG Volume (30 Days)
- RHE 27.3K
- XXII 9.6M
- Earning Date
- RHE 11-29-2024
- XXII 11-12-2024
- Dividend Yield
- RHE N/A
- XXII N/A
- EPS Growth
- RHE N/A
- XXII N/A
- EPS
- RHE N/A
- XXII N/A
- Revenue
- RHE $15,936,000.00
- XXII $9,918,000.00
- Revenue This Year
- RHE N/A
- XXII $56.94
- Revenue Next Year
- RHE N/A
- XXII $2.98
- P/E Ratio
- RHE N/A
- XXII $0.03
- Revenue Growth
- RHE N/A
- XXII N/A
- 52 Week Low
- RHE $1.13
- XXII $0.09
- 52 Week High
- RHE $3.08
- XXII $5.28
- Technical
- Relative Strength Index (RSI)
- RHE 43.01
- XXII 31.38
- Support Level
- RHE $1.13
- XXII $0.09
- Resistance Level
- RHE $2.11
- XXII $0.13
- Average True Range (ATR)
- RHE 0.15
- XXII 0.01
- MACD
- RHE -0.04
- XXII 0.01
- Stochastic Oscillator
- RHE 44.90
- XXII 10.51
About RHE Regional Health Properties Inc.
Regional Health Properties Inc is a self-managed healthcare real estate investment company that invests in real estate purposed for senior living and long-term healthcare through facility lease and sub-lease transactions. It has two reportable segments real estate segment and the healthcare services segment. It derives the majority of its revenue from the healthcare services segment. Its portfolio of properties is diversified across various states, with concentrations in Georgia and Ohio.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.